Alertas Bibliograficas – Diabetes

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure Packer M, Anker S  Butler J et al for the EMPEROR-Reduced Trial Investigators N Engl J Med. 2020 Aug 29. http://doi.org/10.1056/NEJMoa2022190

Diabetes, Glycated Hemoglobin, and the Risk of Myocardial Infarction in Women and Men: A Prospective Cohort Study of the UK Biobank De Jong M, Woodward M and  Peters S Diabetes Care. 2020 Sep;43(9):2050-2059. http://doi.org/10.2337/dc19-2363

Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes Hydes TJ, Summers N, Brown E, et al. Diabet Med. 2020 Jul 3. http://doi.org/10.1111/dme.14356

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial Perkovic V.; Toto R, Cooper ME. et al. Diabetes Care. 2020 Aug; 43(8): 1803–1812....

High-protein meals require 30% additional insulin to prevent delayed postprandial hyperglycaemia Paterson MA, Smart CEM, Howley P, Price DA, et al. Diabet Med. 2020 Jul;37(7):1185-1191. www.doi.org/10.1111/dme.14308

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC JAMA. 2020 Jul 10. www.doi.org/10.1001/jama.2020.12839

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study Cariou, B., Hadjadj, S., Wargny, M. et al. Diabetologia. 2020 May 29;1-16. http://www.doi.org/10.1007/s00125-020-05180-x

Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA 1c, in Patients With Type 2 Diabetes Ali A, Martinez R, Al-Jobori H, Adams J, Triplitt C, DeFronzo R, et al. Diabetes Care 2020 Jun;43(6):1234-1241....

Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Braffett BH, Gubitosi-Klug RA, Albers JW, et al.;...

Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications. Drucker DJ Endocr Rev. 2020 Jun 1;41(3). http://www.doi.org/10.1210/endrev/bnaa011